Brookings issues recommendations for generic drug competition as PDUFA VI expiration looms
While the FDA, industry insiders and politicians have all weighed in on what the newest iteration of PDUFA should look like, a new report from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
